Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-aminolevulinic acid for photodynamic diagnosis of upper urinary tract urothelial carcinoma
jRCTs051200004Phase 2Completed
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of 5-aminolevulinic acid in upper tract urothelial carcinoma (UTUC). Primary endpoint: Progression-free survival duration. Started Mar 2020; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
upper tract urothelial carcinoma (UTUC)
Beyond the preview
Go deeper on jRCTs051200004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051200004.